AMRUTANJAN493.35

Amrutanjan Health Care Limited

· Pharma & Health
₹ CrorePeersJAGSNPHARMNGLFINESIGACHILINCOLNSYNCOMFTHEMISMEDHESTERBIOMcap ₹1,426 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment47.247.749.849.8
+ Capital Work-in-Progress2.316.2105.5105.5
+ Other Intangibles2.31.71.41.4
+ Intangibles under Development0.10.10.20.2
+ Non-current Investments0.00.00.00.0
+ Other Non-current Financial Assets11.841.746.246.2
Non-current Financial Assets11.841.746.246.2
+ Deferred Tax Assets3.23.15.35.3
+ Other Non-current Assets4.320.38.78.7
Total Non-current Assets71.2130.7217.2217.2
Current Assets
+ Inventories28.927.337.437.4
+ Current Investments0.00.03.13.1
+ Trade Receivables47.955.860.660.6
+ Cash & Cash Equivalents3.710.211.311.3
+ Other Bank Balances22.973.022.122.1
+ Other Current Financial Assets184.7116.2142.3142.3
Current Financial Assets259.2255.1239.4239.4
+ Other Current Assets7.68.314.914.9
Total Current Assets295.7290.7291.6291.6
Total Assets366.9421.4508.9508.9
Equity
+ Equity Share Capital2.92.92.92.9
+ Other Equity / Reserves285.6323.7367.3367.3
Equity — Owners of Parent288.5326.6370.2370.2
Total Equity288.5326.6370.2370.2
Liabilities
+ Other Non-current Financial Liab1.61.01.0
Non-current Financial Liabilities1.60.01.01.0
+ Provisions — Non-current6.98.310.010.0
+ Other Non-current Liabilities0.01.91.41.4
Non-current Liabilities8.510.212.512.5
+ Trade Payables55.969.070.970.9
+ Other Current Financial Liab2.02.129.429.4
Current Financial Liabilities57.971.1100.3100.3
+ Provisions — Current2.02.310.610.6
+ Current Tax Liabilities1.61.75.15.1
+ Other Current Liabilities8.49.410.310.3
Current Liabilities69.984.6126.2126.2
Total Liabilities78.494.8138.7138.7
Total Equity & Liabilities366.9421.4508.9508.9
Trade Payables — MSME split
+ Dues to Micro & Small — Current1.93.43.4
+ Dues to Other Creditors — Current67.167.567.5
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.